Smith+Nephew announced the launch of its RENASYS EDGE Negative Pressure Wound Therapy System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact allowing it to be easily carried or worn, it features a discreet canister, and operates quietly so as not to draw attention or disturb the patients? daily activities.

It is estimated that the annual financial burden of chronic wounds in the US is $33 billion, and affecting some 8.2 million people. The RENASYS EDGE System is designed for patients suffering from these wounds and living at home. Chronic wounds, including ulcers, have a huge impact on a patient?s life beyond just the pain and discomfort, with 68% often becoming self-conscious of their wound and many becoming isolated.

The need to carry a bulky, noisy medical device that draws attention to their condition only increases this discomfort. Smith+Nephew is also announcing two new national distribution partners for the RENASYS EDGE System - SunMED Medical Solutions and First Nation Group. These new partnerships will enable Smith+Nephew to introduce this new, innovative technology to more patients on a national level and support its growing negative pressure wound therapy business.

For clinicians, the RENASYS EDGE system is intuitive and easy-to-use. Its user-friendly interface gives step-by-step guidance on therapy application, and technical support is just one click away during set up with the near field communication feature on the system. Additionally, Smith+Nephew provides 24-hour customer support for patients and a clinical hotline.